Largan Health AI-Tech Co., Ltd.
Update:2026/11/10
Industries
Main Industry
Health Care
Main Product/Service
Next-Generation Sleep Testing, ECG Monitor, Sleep Monitoring System
The content above was translated by Ai
Founded Year
2019
Unified Business No.
82801747
Status
Active
Number of Employees
0
Total Paid-in
Capital
80,000,000 (NT$)
Location of Company
Taiwan
, Taipei City
Company names, registration status, legal representatives, founding years, paid-in capital, registered addresses, and other details are sourced from business registration records maintained by Taiwan’s Administration of Commerce, Ministry of Economic Affairs. Exit status includes Emerging Stock Board listings, M&A, and IPOs. Information on overseas expansion is self-reported by startups.
Note 1: FINDIT compiles company information from public and other sources for reference and does not serve as a point of contact for the companies listed.
Note 2: Some company profiles and product/service descriptions are translated using AI and provided for reference only. In case of discrepancies or ambiguity, the original text prevails.
Exclusive content for members
Members-only content. Please log in to access.
About the Company
We are the first company in Taiwan to have a medical-certified AI sleep cloud, and our testing product is the first in Taiwan to simultaneously complete multi-center clinical validation studies with National Taiwan University Hospital, Taipei Veterans General Hospital, China Medical University Hospital, and Hualien Tzu Chi Hospital.
Largan Health AI-Tech Co., Ltd. is a subsidiary established in 2019 through reinvestment by Largan Precision, dedicated to the research, development, and promotion of medical-grade professional cloud-based physiological testing and monitoring systems for clinical and home applications.
Referencing the spirit of the Cardiopulmonary Coupling (CPC) theory from Harvard Medical School and integrating other relevant dynamic physiological indicators, we have refined and innovated through Taiwan's sleep medicine research and ICT-AI technology to develop multiple medical-grade hardware and software products, establishing a national innovative medical-grade sleep cloud. This allows physicians and the public to measure physiological signals during nighttime sleep in a precise and more comfortable manner, thereby analyzing physiological information such as sleep apnea, sleep quality, sleeping posture, body movement, nighttime awakenings, heart rate variability (HRV), blood oxygen desaturation, arrhythmia rapid screening, autonomic nervous system dysfunction, and so on, with the hope of contributing to sleep health.
Cardiopulmonary Coupling (CPC) theory is a mature sleep academic theory researched for many years by Harvard Medical School. However, transforming laboratory academic theory into a clinically convenient, precise product and achieving commercial operation faces numerous challenges and requires many modifications and breakthroughs.
Largan Health AI-Tech Co., Ltd. has successfully combined Taiwan's strengths in advanced medicine, ICT, IoT, and AI machine learning to research, develop, and launch the DOMII® advance nighttime physiological signal analysis technology.
DOMII® advance integrates physiological recording equipment self-developed by Taiwan's Largan Precision. From physiological signal sampling, filtering, to storage, it utilizes custom-tailored, exclusive data processing methods to ensure the capture of the most complete and distortion-free physiological signals. Combined with years of accumulated clinical test data and AI machine learning methods, this has improved analysis accuracy.
The advanced version, DOMII® advance, further integrates electrocardiogram (ECG), respiration, and blood oxygen physiological information wirelessly, providing physicians with more auxiliary diagnostic physiological information through high-level precise analysis to perform precision medicine. At the same time, it achieves the goal of "wireless and unobstructed, infinitely pleasant" physiological monitoring during sleep.
During the Annual Meeting of the Taiwan Society of Sleep Medicine on October 1-2, 2022, the results of the multi-center clinical validation conducted by the three institutions—Taipei Veterans General Hospital, China Medical University Hospital, and Hualien Tzu Chi Hospital—were presented as a poster. According to the research results, the comparative analysis between our company's product and PSG testing demonstrated high accuracy, high sensitivity, and high specificity.
Largan Health AI-Tech Co., Ltd. is a subsidiary established in 2019 through reinvestment by Largan Precision, dedicated to the research, development, and promotion of medical-grade professional cloud-based physiological testing and monitoring systems for clinical and home applications.
Referencing the spirit of the Cardiopulmonary Coupling (CPC) theory from Harvard Medical School and integrating other relevant dynamic physiological indicators, we have refined and innovated through Taiwan's sleep medicine research and ICT-AI technology to develop multiple medical-grade hardware and software products, establishing a national innovative medical-grade sleep cloud. This allows physicians and the public to measure physiological signals during nighttime sleep in a precise and more comfortable manner, thereby analyzing physiological information such as sleep apnea, sleep quality, sleeping posture, body movement, nighttime awakenings, heart rate variability (HRV), blood oxygen desaturation, arrhythmia rapid screening, autonomic nervous system dysfunction, and so on, with the hope of contributing to sleep health.
Cardiopulmonary Coupling (CPC) theory is a mature sleep academic theory researched for many years by Harvard Medical School. However, transforming laboratory academic theory into a clinically convenient, precise product and achieving commercial operation faces numerous challenges and requires many modifications and breakthroughs.
Largan Health AI-Tech Co., Ltd. has successfully combined Taiwan's strengths in advanced medicine, ICT, IoT, and AI machine learning to research, develop, and launch the DOMII® advance nighttime physiological signal analysis technology.
DOMII® advance integrates physiological recording equipment self-developed by Taiwan's Largan Precision. From physiological signal sampling, filtering, to storage, it utilizes custom-tailored, exclusive data processing methods to ensure the capture of the most complete and distortion-free physiological signals. Combined with years of accumulated clinical test data and AI machine learning methods, this has improved analysis accuracy.
The advanced version, DOMII® advance, further integrates electrocardiogram (ECG), respiration, and blood oxygen physiological information wirelessly, providing physicians with more auxiliary diagnostic physiological information through high-level precise analysis to perform precision medicine. At the same time, it achieves the goal of "wireless and unobstructed, infinitely pleasant" physiological monitoring during sleep.
During the Annual Meeting of the Taiwan Society of Sleep Medicine on October 1-2, 2022, the results of the multi-center clinical validation conducted by the three institutions—Taipei Veterans General Hospital, China Medical University Hospital, and Hualien Tzu Chi Hospital—were presented as a poster. According to the research results, the comparative analysis between our company's product and PSG testing demonstrated high accuracy, high sensitivity, and high specificity.
The content above was translated by Ai